United Therapeutics Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Thank you, Ben. Really appreciate it. Always really good work to make it so easy for us. Hey, everybody. We have today for our first day of the Oppenheimer Healthcare Conference, one of the companies I have been following for a long time called United Therapeutics. Their Chief Financial Officer, James; and Patrick, Head of Technical Ops, if I'm not mistaken. Sorry, if I give you a promotion, Patrick, or maybe not. But we have both of them joining us today for a conversation.
So both of you, welcome. And James, maybe you could start off with about a 3- to 5-minute state-of-the-business intro. But really appreciate having both of you here.
Yes. Good morning, Hartaj. Really first, I want to thank you for inviting us to the fireside chat this morning and Oppenheimer for the opportunity to join the conference now, as I mentioned, but also throughout the day.
And before I jump into it, Hartaj, let
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |